Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Fournier

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|January 28, 1999
Characterization of a silencer element and purification of a silencer protein that negatively regulates the human adenine nucleotide translocator 2 promoterP Baráth, B Albert-Fournier, K Luciaková, et al.
Lancet (London, England)|May 22, 2002
Renoprotection with antihypertensive agentsAlbert Fournier, Claire Presne, Raïfah Makdassi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 5, 2002
Progression of vascular calcification and dyslipidemia in patients on chronic hemodialysisRoxana Oprisiu, Delia Bunea, Sadek Tarek, et al.
Lancet (London, England)|March 28, 2003
The COOPERATE trialClaire Presne, Janette Mansour, Raïfah Makdassi, et al.
Lancet (London, England)|December 14, 2002
The OPTIMMAL trial: losartan or captopril after acute myocardial infarctionAlbert Fournier, Michel Andrejak, Michel Slama, et al.
JAMA|February 15, 2003
Losartan vs atenolol in prevention of stroke and cardiovascular diseaseAlbert Fournier, Roxana Oprisiu, Michel Andrejak, et al.
Journal of Hypertension|March 19, 2005
VALUE and supremacy of blood pressure control for cardiovascular protectionAlbert Fournier, Janet Mansour, Hakim Mazouz, et al.
JAMA|April 17, 2003
Reducing the risk of strokeAlbert Fournier, Roxana Oprisiu, Michel Andrejak, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2006
Current treatment options in secondary renal hyperparathyroidismJean-François Bonne, Jeanette Mansour, Philippe Moriniere, et al.
Lancet (London, England)|December 7, 2007
The JIKEI trialFlorent Boutitie, François Gueyffier, Jean-Michel Achard, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|January 28, 1999
Characterization of a silencer element and purification of a silencer protein that negatively regulates the human adenine nucleotide translocator 2 promoterP Baráth, B Albert-Fournier, K Luciaková, et al.
Lancet (London, England)|May 22, 2002
Renoprotection with antihypertensive agentsAlbert Fournier, Claire Presne, Raïfah Makdassi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 5, 2002
Progression of vascular calcification and dyslipidemia in patients on chronic hemodialysisRoxana Oprisiu, Delia Bunea, Sadek Tarek, et al.
Lancet (London, England)|March 28, 2003
The COOPERATE trialClaire Presne, Janette Mansour, Raïfah Makdassi, et al.
Lancet (London, England)|December 14, 2002
The OPTIMMAL trial: losartan or captopril after acute myocardial infarctionAlbert Fournier, Michel Andrejak, Michel Slama, et al.
JAMA|February 15, 2003
Losartan vs atenolol in prevention of stroke and cardiovascular diseaseAlbert Fournier, Roxana Oprisiu, Michel Andrejak, et al.
Journal of Hypertension|March 19, 2005
VALUE and supremacy of blood pressure control for cardiovascular protectionAlbert Fournier, Janet Mansour, Hakim Mazouz, et al.
JAMA|April 17, 2003
Reducing the risk of strokeAlbert Fournier, Roxana Oprisiu, Michel Andrejak, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2006
Current treatment options in secondary renal hyperparathyroidismJean-François Bonne, Jeanette Mansour, Philippe Moriniere, et al.
Lancet (London, England)|December 7, 2007
The JIKEI trialFlorent Boutitie, François Gueyffier, Jean-Michel Achard, et al.
Pageof 8